France’s Economy and Industry ministers, Antoine Armand and Marc Ferracci, are heading to Lisieux this Monday to visit the production sites of popular headache reliever Doliprane. The visit takes place after the maker of the pill, French pharma group Sanofi, said it was in talks to sell off its consumer health business to a US private equity firm. The deal has raised fears for French health sovereignty and job security. We also take a look at the 2024 Paris Motor Show, which kicks off Monday.
Related Posts
European Commission president unveils who will get key economic portfolios
After weeks of negotiations, European Commission chief Ursula Von der Leyen has unveiled her top team – giving key economic portfolios to France, Italy and […]
Plastic Planet: UN talks fail to curb production
The world produces some 400 million tonnes of plastic waste every year. About half of all plastic is designed to be single use, that is, thrown […]
Trump vows steep tariffs on Mexico, Canada and China over drug trafficking, migration
US President-elect Donald Trump has announced that he will slap a 25 percent across-the-board tariffs on all imports from Mexico and Canada unless they stop […]